Genomma Lab Internacional SAB de CV
BMV:LABB
Genomma Lab Internacional SAB de CV
BMV:LABB
Price:
18.88
MXN
2.11%
Market Closed
Market Cap:
Mex$18.9B
Relative Value
The Relative Value of one
LABB
stock under the Base Case scenario is
26.65
MXN.
Compared to the current market price of 18.88 MXN,
Genomma Lab Internacional SAB de CV
is
Undervalued by 29%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LABB
Relative Value
Base Case
26.65
MXN
Undervaluation 29%
Multiples Across Competitors
LABB Competitors Multiples
Genomma Lab Internacional SAB de CV Competitors
Genomma Lab Internacional SAB de CV Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| MX |
|
Genomma Lab Internacional SAB de CV
BMV:LABB
|
18.4B MXN | 1.1 | 11.5 | 5.1 | 5.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
866.9B USD | 13.3 | 42 | 28.4 | 30.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
572.1B USD | 6.1 | 21.3 | 14.8 | 18.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
250.6B CHF | 4.1 | 19.5 | 11.5 | 13 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
217.9B GBP | 5 | 28.6 | 15.9 | 22.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
225.9B CHF | 5.2 | 20.8 | 12.9 | 16.5 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
282.6B USD | 4.3 | 15.5 | 9.6 | 11.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
240.1B USD | 103.6 | -82.1 | 380.1 | 953.2 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.9B USD | 2.5 | 20.1 | 7.7 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117B USD | 2.4 | 16.6 | 7 | 8.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
